Insulin delivery devices are proliferating despite equitable insulin access bein...
As US drug prices increase, consumers are turning to illegal online pharmacies t...
Patients with DEB have extremely fragile skin that blisters and tears with minor...
The U.K. government on Thursday unveiled an $800 million package to bolster the ...
In a new study, a medicine from Bristol Myers Squibb nearly doubled the treatmen...
“We’ve lost an opportunity to have direct government purchases of hundreds of th...
Can AI diagnose a disease? Are Wegovy's days numbered? And what makes AI halluci...
Illumina shareholders elect one of Carl Icahn's allies to board, but the company...
The FDA delayed its decision on a gene therapy for Duchenne muscular dystrophy a...
Adopting the term "preaddiction" could have potentially disastrous consequences ...
Medicare’s coverage decision has revived longstanding questions about how the fe...
We have an obligation not to leave any useful data on the metaphorical cutting r...
A small club of billionaires is using unorthodox tactics — and piles of cash and...
A new study found that ketamine performs at least as well as ECT, the current go...
Matt Eyles, who led AHIP for five years, is leaving the group. His departure sur...
Boston Scientific is scrapping its $230 million plan to buy a majority stake in ...
